Jung Won Lee Selected Research

New York protocol

11/2013

Should children with non-Hodgkin lymphoma be treated with different protocols according to histopathologic subtype?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jung Won Lee Research Topics

Disease

6	Infections 06/2020 - 10/2010
6	Neoplasms (Cancer) 01/2019 - 08/2010
3	Pyelonephritis 01/2018 - 02/2009
3	Overactive Urinary Bladder (Overactive Bladder) 01/2015 - 12/2011
2	Obesity 01/2021 - 12/2006
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2021 - 11/2018
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2020 - 02/2016
2	Colitis 12/2020 - 02/2016
2	Urinary Tract Infections (Urinary Tract Infection) 01/2018 - 10/2016
2	Stomach Neoplasms (Stomach Cancer) 03/2017 - 03/2017
2	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 01/2014 - 09/2007
2	Phimosis 02/2009 - 08/2006
1	Diabetes Mellitus 03/2022
1	Hyperglycemia 03/2022
1	Hypertension (High Blood Pressure) 02/2022
1	Fibrosis (Cirrhosis) 02/2022
1	Hemorrhage 02/2022
1	Prostatic Neoplasms (Prostate Cancer) 02/2022
1	Dyspepsia (Indigestion) 01/2021
1	Insulin Resistance 01/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	Weight Loss (Weight Reduction) 12/2020
1	Fatty Liver 09/2019
1	Birth Weight (Birth Weights) 07/2019
1	Colorectal Neoplasms (Colorectal Cancer) 01/2019
1	Sepsis (Septicemia) 01/2018
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Carcinogenesis 03/2017
1	Retinoblastoma (Glioblastoma, Retinal) 09/2016
1	Tuberculosis (Tuberculoses) 07/2015
1	Inflammation (Inflammations) 07/2015
1	Leukopenia 07/2015
1	Cicatrix (Scar) 04/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2013
1	Takotsubo Cardiomyopathy 12/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2013
1	Lymphoma (Lymphomas) 11/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2013
1	Gastroesophageal Reflux (GERD) 07/2013
1	Substance-Related Disorders (Drug Abuse) 07/2013
1	Esophagitis 07/2013

Drug/Important Bio-Agent (IBA)

3	Glucose (Dextrose)FDA LinkGeneric 03/2022 - 09/2019
3	Triglycerides (Triacylglycerol)IBA 03/2022 - 09/2019
2	Blood Glucose (Blood Sugar)IBA 03/2022 - 09/2019
2	oxidized low density lipoproteinIBA 01/2021 - 09/2019
2	Dextran SulfateIBA 12/2020 - 02/2016
2	Protein Isoforms (Isoforms)IBA 12/2020 - 01/2019
2	CytokinesIBA 12/2020 - 12/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2016 - 09/2007
2	Cholinergic Antagonists (Anticholinergics)IBA 01/2015 - 11/2014
2	Proton Pump InhibitorsIBA 08/2014 - 07/2013
2	AutoantibodiesIBA 12/2013 - 12/2005
2	SteroidsIBA 08/2006 - 12/2005
1	AnticoagulantsIBA 02/2022
1	Insulin (Novolin)FDA Link 01/2021
1	AlbuminsIBA 01/2021
1	mosaprideIBA 01/2021
1	Rabeprazole (Aciphex)FDA Link 01/2021
1	LeptinIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 12/2020
1	CKD-506IBA 12/2020
1	Histone Deacetylase 6IBA 12/2020
1	BismuthIBA 06/2020
1	LDL CholesterolIBA 09/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2019
1	HDL CholesterolIBA 09/2019
1	Uric Acid (Urate)IBA 07/2019
1	glucose-regulated proteinsIBA 01/2019
1	Rituximab (Mabthera)FDA Link 11/2018
1	Monoclonal AntibodiesIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 03/2017
1	DesminIBA 09/2016
1	Retinoblastoma ProteinIBA 09/2016
1	NF-kappa B (NF-kB)IBA 02/2016
1	lupeolIBA 02/2016
1	Moxifloxacin (Avelox)FDA Link 12/2015
1	FluoroquinolonesIBA 12/2015
1	Levofloxacin (Levaquin)FDA Link 12/2015
1	finafloxacinIBA 12/2015
1	Immunologic Factors (Immunomodulators)IBA 07/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2015
1	2-mercaptopurineIBA 07/2015
1	Virulence Factors (Pathogenicity Factors)IBA 05/2014
1	Hyaluronic Acid (Hyaluronan)IBA 01/2014
1	dextranomerIBA 01/2014
1	Immunoglobulin A (IgA)IBA 12/2013
1	Immunoglobulins (Immunoglobulin)IBA 12/2013
1	ChemokinesIBA 12/2013
1	squamous cell carcinoma-related antigenIBA 09/2013

Therapy/Procedure

8	Therapeutics 01/2021 - 12/2006
2	Radiotherapy 02/2022 - 09/2013
2	Oral Administration 12/2020 - 02/2016
2	Antibiotic Prophylaxis 11/2016 - 04/2015
1	Anesthesia 12/2013
1	New York protocol 11/2013
1	Drug Therapy (Chemotherapy) 11/2013
1	Induction Chemotherapy 11/2013
1	Neoadjuvant Therapy 09/2013